Clinical trial reportAdvances in therapyPublished
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Advances in therapy
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Sclerosis, Relapsing-Remitting; Immunosuppressive Agents; Treatment Outcome; Age Factors; Adult; Aged; Middle Aged; Female; Male; Dimethyl Fumarate; Safety
- PubMed ID
- 39570545
- PubMed Central ID
- PMC11782338
- Open access
- Yes, open
- Added to directory
- Source checked